BAX three-lens brief
Evidence-based stock research on BAX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $28.73 — 19% above current (11 analysts). · P/E of 86 — priced for high growth; little margin of safety.
- P/E of 86 — priced for high growth; little margin of safety.
- Analyst mean target $28.73 — 19% above current (11 analysts).
BAX closed at $24.18 (-0.86%) as of 2026-09-11. Market cap: $12.50B. P/E (trailing) 86.3. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $28.73 — 19% above current (11 analysts).. Concerns: p/E of 86 — priced for high growth; little margin of safety.. Last quarter: Revenue $2.96B, net income $126.00M, free cash flow $1.00B.
Why three lenses on BAX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BAXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BAX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BAX brief"></iframe>